慢性肝病眼部表现介绍*

doi:10.3969/j.issn.1672-5069.2026.05.040

摘要/Abstract

摘要： 肝脏疾病可通过代谢紊乱、病毒感染、免疫异常等多种途径引发眼部异常,此类眼部体征与肝脏病理学改变存在密切的内在关联,可为肝脏疾病的早期诊断、病情监测提供重要的辅助依据。本文系统梳理了PubMed数据库中相关文献,重点阐述不同类型肝脏疾病的眼部表现特征,分析其发病机制,并总结眼部体征在肝病诊断方面的临床应用价值。

关键词: 肝病, 眼部表现, 辅助诊断

Abstract: Liver diseases can lead to ocular abnormalities through diverse mechanisms, including metabolic disturbances, viral infections and immune dysregulation. These ocular manifestations are closely correlated with hepatic pathological changes and may serve as an important auxiliary indicator for early diagnosis and disease monitoring of liver diseases. This review systematically searches literature in PubMed database, with a focus on characterizing the ocular features associated with different types of liver diseases, analyzing their pathogenic mechanisms, and summarizing the clinical implication of ocular signs in hepatological diagnosis.

Key words: Liver diseases, Ocular manifestations, Diagnosis

阮方, 孔文君. 慢性肝病眼部表现介绍^*[J]. 实用肝脏病杂志, 2026, 29(5): 796-799.

Ruan Fang, Kong Wenjun. Ocular manifestations of chronic liver diseases[J]. Journal of Practical Hepatology, 2026, 29(5): 796-799.

参考文献

[1] Patel R, Nair S, Choudhry H,et al. Ocular manifestations of liver disease: an important diagnostic aid. Int Ophthalmol, 2024, 44(1): 177.
[2] Chen C, Wei L, He W,et al. Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study. E Clin Med, 2024, 68: 102424.
[3] Vitiello L, De Bernardo M, Guercio Nuzio S,et al. Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other. Dig Liver Dis, 2020, 52(1): 1-8.
[4] Humbertjean-Selton L, Selton J, Riou-Comte N,et al. Bilateral optic neuropathy related to severe anemia in a patient with alcoholic cirrhosis: a case report and review of the literature. Clin Mol Hepatol, 2018, 24(4): 417-423.
[5] Cumurcu T, Gunduz A, Cumurcu BE,et al. The changes in tear film parameters and impression cytology in heavily drinking men. Cornea, 2013, 32(3): 237-241.
[6] Ghosh AK, Čsna R, Neverauskas D,et al. Dietary alcohol consumption elicits corneal toxicity through the generation of cellular oxidative stress. J Ocul Pharmacol Ther, 2023, 39(5): 303-316.
[7] Yang YT, Ji MR, Lin ZJ,et al. Bile duct ligation impairs visual acuity in rats by ammonia- and bilirubin-induced retinal degeneration. Acta Pharmacol Sin, 2025, 46(2): 380-392.
[8] Kuo BL, Muste JC, Russell MW,et al. Evidence for the hepato-retinal axis: A systematic review. Ophthalmic Surg Lasers Imaging Retina, 2024, 55(10): 587-596.
[9] Sohal RJ, Singh P, Sandhu SS,et al. A rare cause of bilateral corneal ulcers: vitamin A deficiency in the setting of chronic alcoholism. Cureus, 2020, 12(5): e7991.
[10] Goel S, Aggarwal N, Sharma A,et al. Ocular manifestations of Wilson's disease. BMJ Case Rep, 2019, 2019: bcr2019202516.
[11] Rubio-Gozalbo ME, van der Meer S, Monnens LA, et al. The natural history of classic galactosemia: lessons from the GalNet registry. Orphanet J Rare Dis, 2019, 14(1): 86.
[12] Rajappa M, Goyal A, Kaur J. Inherited metabolic disorders involving the eye: a clinico-biochemical perspective. Eye (Lond), 2010, 24(4): 507-518.
[13] Hingorani M, Goldfarb DS, Rand EB,et al. Ocular abnormalities in Alagille syndrome. Ophthalmology, 1999, 106(2): 330-337.
[14] Folz SJ, Trobe JD. The peroxisome and the eye. Surv Ophthalmol, 1991, 35(5): 353-368.
[15] Colburn JD, Skelo AS, Donahue SP. Corneal ulceration due to vitamin A deficiency in Zellweger syndrome. J AAPOS, 2009, 13(3): 289-291.
[16] Ajzensztejn MJ, Hulton SA, Gill D, et al. Primary hyperoxaluria type 1. Arch Dis Child, 2007, 92(3): 197.
[17] Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr, 2018, 44(Suppl 2): 125.
[18] Ashworth JL, Clarke AJ, Hollingsworth DR,et al. Mucopolysaccharidoses and the eye. Surv Ophthalmol, 2006, 51(1): 1-17.
[19] Libert J, Toussaint D, Guiselings R. Ocular findings in Niemann-Pick disease. Am J Ophthalmol, 1975, 80(6): 991-1002.
[20] Tsoumani A, Theopistos V, Katsanos A, et al. Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C. Eur Rev Med Pharmacol Sci, 2013, 17(8): 1123-1131.
[21] d'Alteroche L, Majzoub S, Lecuyer AI,et al. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. J Hepatol, 2004, 40(4): 706-707.
[22] Raza A, Mittal S, Sood GK. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review. J Viral Hepat, 2013, 20(9): 593-599.
[23] Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Interferon Cytokine Res, 1998, 18(8): 569-572.
[24] Bertrand RHC, de Oliveira DM, de Freitas MR,et al. An eye on hepatitis C: a review. Arq Bras Oftalmol, 2019, 82(2): 161-167.
[25] Zeni LP, Viera SM, Mello FC,et al. Hepatitis C virus induces abnormalities in surface and intraocular pressure: a comparative study. Eur J Gastroenterol Hepatol, 2013, 25(4): 411-415.
[26] Gumus K, Erden A, Yilmaz O,et al. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis. Cornea, 2009, 28(9): 997-1002.
[27] Wilson SE, Foster CS, Azar DT,et al. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology, 1994, 101(4): 736-745.
[28] Yeh CC, Chen YC, Yang YH, et al. Association of SjÏgrens syndrome in patients with chronic hepatitis virus infection: a population-based analysis. PLoS One, 2016, 11(8): e0161958.
[29] Citirik M, Erdem E, Gurel S,et al. Ocular findings in patients with autoimmune liver disease. Ocul Immunol Inflamm, 2012, 20(6): 438-442.
[30] Eshraghi H, Mahtabfar A, Dastjerdi MH. A case of peripheral ulcerative keratitis associated with autoimmune hepatitis. Case Rep Med, 2017, 2017: 3939413.
[31] Romanelli RG, Bianchi FB, de Souza AP,et al. Uveitis in autoimmune hepatitis: a case report. World J Gastroenterol, 2006, 12(10): 1637-1640.
[32] Liang Y, Li J, Wang Y, et al. Extrahepatic conditions of primary biliary cholangitis: a systematic review and meta-analysis of prevalence and risk. Clin Res Hepatol Gastroenterol, 2024, 48(5): 102321.
[33] Deng X, Li J, Hou M, et al. Prevalence and impact of SjÏgren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis. Ann Hepatol, 2022, 27(6): 100746.
[34] Li S, Li A, Zhu Y, et al. Evaluation of the clinical characteristics of dry eye secondary to different types of liver diseases. Ophthalmol Ther, 2023, 12(5): 2493-2503.
[35] Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol, 2011, 1(3): 177-184.

慢性肝病眼部表现介绍^*

Ocular manifestations of chronic liver diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王佳颖, 张濛销, 汤善宏. 慢性肝病患者肝自主神经系统病理生理作用及其机制研究进展[J]. 实用肝脏病杂志, 2026, 29(5): 645-648.
[2]	姚秋月, 雷云霞. 芪茵颗粒通过调控SIRT1/LXRα信号通路影响代谢相关脂肪性肝病小鼠肝组织脂质代谢研究^*[J]. 实用肝脏病杂志, 2026, 29(5): 657-660.
[3]	李静, 张文杰, 杨晓娟, 马蓉霞, 陈芳芳. 非酒精性脂肪性肝病患者肝脂肪变性严重程度对肠道菌群的影响^*[J]. 实用肝脏病杂志, 2026, 29(5): 669-672.
[4]	陈丽虹, 刘银辉, 高梅芳, 李品娣, 吴伟新, 张玮, 李洪昌. 肝病专用型肠内营养制剂治疗失代偿期乙型肝炎肝硬化患者临床疗效研究^*[J]. 实用肝脏病杂志, 2026, 29(5): 705-708.
[5]	赵宇皓, 张和钊, 张瑞, 史志勇, 樊永强, 刘晓东, 徐钧. 基于血清IL-34、ADR和MELD评分构建早期移植物功能障碍预警模型:一项肝移植预后评估研究^*[J]. 实用肝脏病杂志, 2026, 29(5): 745-748.
[6]	吴芃萱, 刘晖, 郑素军. 伴有脂肪肝的遗传代谢性肝病诊断策略^*[J]. 实用肝脏病杂志, 2026, 29(4): 481-484.
[7]	刘江, 袁涵, 凌芬, 李东海. 脯氨酸加格列净通过抑制DPP4/NOX1介导的氧化应激反应改善代谢相关脂肪性肝病小鼠肝脂肪变性^*[J]. 实用肝脏病杂志, 2026, 29(4): 489-492.
[8]	赵懿孺, 谢伟龙, 石丽莎, 潘修成, 王霞. 1990～2023年金砖国家非酒精性脂肪性肝病疾病负担变化^*[J]. 实用肝脏病杂志, 2026, 29(4): 509-512.
[9]	刘莹, 马小宏, 孙长江, 陈爱莲. 超声脂肪分数联合RC/HDL-C比值评估MAFLD患者肝脂肪变性程度价值研究^*[J]. 实用肝脏病杂志, 2026, 29(4): 513-516.
[10]	郭鸿雁, 王蕊, 孙倩. 2型糖尿病合并非酒精性脂肪性肝病患者血糖控制水平与氧化应激和早期肝纤维化的关系探讨[J]. 实用肝脏病杂志, 2026, 29(4): 521-524.
[11]	彭艳侠, 翟盟. 超声衰减成像联合BMI诊断肥胖儿童代谢功能障碍相关性脂肪性肝病价值研究^*[J]. 实用肝脏病杂志, 2026, 29(4): 525-528.
[12]	朱晨晨, 庄晓晨, 杨凌菲, 王颖鑫. 基于QUS技术判定非酒精性脂肪性肝病患者肝脂肪变性分级价值研究^*[J]. 实用肝脏病杂志, 2026, 29(4): 529-532.
[13]	杨鸿, 赖会君, 马磊, 胡明超, 沈晓东, 张金秀. 超声弹性成像参数联合血清肝纤维化指标评估血吸虫病性肝病患者肝纤维化程度价值研究^*[J]. 实用肝脏病杂志, 2026, 29(4): 561-564.
[14]	李宁, 王燕, 雷红涛, 钟焕巧, 郭琪, 奎翔. 自身免疫性肝病外周血中性粒细胞变化研究进展:机制、诊断与治疗新视角^*[J]. 实用肝脏病杂志, 2026, 29(3): 321-323.
[15]	赵迎娣, 陈钰婷, 宗富强. Fibroscan评估非酒精性脂肪性肝病患者肝脏脂肪变性程度应用研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 345-348.